Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Chronic graft-versus-host disease (GVHD) induced in (C57BL/6 × DBA/2) F1 (BDF1) mice by the injection of DBA/2 mouse spleen cells represents histopathological changes associated with systemic lupus erythematosus (SLE), primary biliary cirrhosis (PBC) and Sjogren's syndrome (SS), as indicated by glomerulonephritis, lymphocyte infiltration into the periportal area of the liver and salivary glands. We determined the therapeutic effect of hepatocyte growth factor (HGF) gene transfection on lupus using this chronic GVHD model. Chronic GVHD mice were injected in the gluteal muscle with either HVJ liposomes containing 8 μg of the human HGF expression vector (HGF-HVJ liposomes) or mock vector (untreated control). Gene transfer was repeated at 2-week intervals during 12 weeks. HGF gene transfection effectively prevented the proteinuria and histopathological changes associated with glomerulonephritis. While liver and salivary gland sections from untreated GVHD mice showed prominent PBC- and SS-like changes, HGF gene transfection reduced these histopathological changes. HGF gene transfection greatly reduced the number of splenic B cells, host B cell major histocompatibility complex class II expression, and serum levels of IgG and anti-DNA antibodies. IL-4 mRNA expression in the spleen, liver, and kidneys was significantly decreased by HGF gene transfection. CD28 expression on DBA/2 CD4+ T cells was decreased by the addition of recombinant HGF in vitro. Furthermore, IL-4 production by DBA/2 CD4+ T cells stimulated by irradiated BDF1 dendritic cells was significantly inhibited by the addition of recombinant HGF in vitro. These results suggest that HGF gene transfection inhibited T helper 2 immune responses and reduced lupus nephritis, autoimmune sialoadenitis, and cholangitis in chronic GVHD mice. HGF may represent a novel strategy for the treatment of SLE, SS and PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increased MET signalling ameliorates disease pathogenesis in several models of classic systemic inflammatory diseases, including multiple sclerosis and systemic lupus erythematosis (SLE) among others38–42.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-894 · Cited by 584
Steinman, R. M. (2002) · Medical Entomology and Zoology · Cited by 446
Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases
Gleichmann, E., Pals, S. T., Rolink, A. G., Radaszkiewicz, T., & Gleichmann, H. (1984) · Immunology Today · doi:10.1016/0167-5699(84)90126-9 · Cited by 342
Sato, K., Yamashita, N., Baba, M., & Matsuyama, T. (2003) · Blood · doi:10.1182/blood-2002-09-2712 · Cited by 247
Burlingame, R. W., Rubin, R. L., Balderas, R. S., & Theofilopoulos, A. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116378 · Cited by 230
Rus, V, Svetic, A., Nguyen, P., Gause, W. C., & Via, C. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2396 · Cited by 222
Research works printed but not linked: 1
- Rus V Svetic A Nguyen P Gause WC Via CS Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells J Immunol 1995 155 2396 2406 7650373 · DOI · Paper page
Cited by
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Novel targets of antifibrotic and anti-inflammatory treatment in CKD
Declèves, A., & Sharma, K. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.31 · Cited by 165
Hepatocyte growth factor: A regulator of inflammation and autoimmunity
Molnarfi, N., Benkhoucha, M., Funakoshi, H., Nakamura, T., & Lalive, P. H. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.013 · Cited by 159
Zhao, Z., Burkly, L. C., Campbell, S., Schwartz, N., Molano, A., Choudhury, A., Eisenberg, R. A., Michaelson, J. S., & Putterman, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7949 · Cited by 148
Pathogenesis of primary biliary cirrhosis
Jones, D. E. J. (2008) · Postgraduate Medical Journal · doi:10.1136/gut.2007.122150 · Cited by 115
Metadata
- Authors
- Kuroiwa, T., Iwasaki, T., Imado, T., Sekiguchi, M., Fujimoto, J., & Sano, H.
- Affiliations
- Hyogo Medical University (JP)
- Corresponding author
- Iwasaki, Tsuyoshi
- Venue
- Arthritis Research & Therapy
- Published
- 2006-07-19
- Volume
- 8
- Issue
- 4
- Pages
- R123-R123
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC1779408
- OpenAlex
- W2120665673
- Cited by
- 39
- References
- 33
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 1 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- hepatocyte growth factor, lupus nephritis, chronic graft-versus-host disease, systemic lupus erythematosus, primary biliary cirrhosis, Sjögren's syndrome, transfection, HVJ-liposome, glomerulonephritis, proteinuria, sialadenitis, cholangitis, IL-4, T helper 2 response, CD28, anti-DNA antibodies, autoimmunity
- MeSH terms
- Animals, Histocompatibility Antigens Class II, Antibodies, Antinuclear, B-Lymphocytes, Cell Differentiation, Chronic Disease, Disease Models, Animal, DNA, Female, Graft vs Host Disease, Humans, Immunoglobulin G, Liver Cirrhosis, Biliary, Lupus Nephritis, Mice, Inbred Strains, Osmolar Concentration, Proteinuria, RNA, Messenger, Sjogren's Syndrome, Spleen, Transfection, CD4-Positive T-Lymphocytes, Down-Regulation, Interleukin-4, Hepatocyte Growth Factor, CD28 Antigens, Th2 Cells, Lymphocyte Count, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.